Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

High-level Expression of a Functional Humanized Anti-Ctla4 Single-Chain Variable Fragment Antibody in Pichia Pastoris.

High-level Expression of a Functional Humanized Single-Chain Variable Fragment Antibody Against CD25 in Pichia Pastoris

Expression and Characterization of Recombinant Humanized Anti-Her2 Single-Chain Antibody in Pichia Pastoris for Targeted Cancer Therapy

Expression of CTLA4Ig Fusion Protein in CHO Cells

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

Expression, purification, and in vitro refolding of a humanized single-chain Fv antibody against human CTLA4 (CD152)☆

Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Construction, Expression and Immunologic Activity of Murine Anti-CTLA-4 ScFv

Soluble Expression and Purification of a Novel Single-Chain Fv Antibody Against Connective Tissue Growth Factor(ctgf/ccn2)

Production and Characterization of a CD25-specific Scfv-Fc Antibody Secreted from Pichia Pastoris

Expression of tumor necrosis factor receptor-immunoglobulin G1 Fc fusion protein in glycoengineered Pichia pastoris

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Construction, Expression and Functional Analysis of Anti-B7-h4-scfv-ch3 Recombinant Antibody

Production and Characterization of LEA29Y, a Variant of Cytotoxic T-lymphocyte Antigen 4-Immunoglobulin, in Pichia Pastoris.

Secretory Expression of Chimeric Fab Antibody HAb18 Against Human Hepatocellular Carcinoma in Pichia Pastoris

Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.

A Strategy for High-Level Expression of a Single-Chain Variable Fragment Against TNFα by Subcloning Antibody Variable Regions from the Phage Display Vector Pcantab 5E into Pbv220.

Production and Characterization of Human Soluble CD83 Fused with the Fragment Crystallizable Region of Human IgG1 in Pichia Pastoris

Cloning Expression and Characterization of a Bi-functional Antibacterial Peptides CM4 and hsBAFF Fusion Protein in Escherichia Coli

[Expression of a Human Single-Chain Fv Antibody Against HBsAg in Pichia Pastoris].